Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
25%
Ph phase_2
3
75%

Phase Distribution

1

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
3(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(3)

Detailed Status

Completed3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (25.0%)
Phase 23 (75.0%)

Trials by Status

recruiting125%
completed375%

Recent Activity

1 active trials
Showing 4 of 4
recruitingphase_2

An Open-Label Study to Evaluate the Safety, Tolerability and Pharmacodynamics of BPL-003 in Patients With Treatment Resistant Depression

NCT05660642
completedphase_2

An Open-Label, Single Dose Study in Patients With Alcohol Use Disorder

NCT05674929
completedphase_2

BPL-003 Efficacy and Safety in Treatment Resistant Depression

NCT05870540
completedphase_1

Single Ascending Dose Study With BPL-003 in Healthy Subjects

NCT05347849

Clinical Trials (4)

Showing 4 of 4 trials
NCT05660642Phase 2

An Open-Label Study to Evaluate the Safety, Tolerability and Pharmacodynamics of BPL-003 in Patients With Treatment Resistant Depression

Recruiting
NCT05674929Phase 2

An Open-Label, Single Dose Study in Patients With Alcohol Use Disorder

Completed
NCT05870540Phase 2

BPL-003 Efficacy and Safety in Treatment Resistant Depression

Completed
NCT05347849Phase 1

Single Ascending Dose Study With BPL-003 in Healthy Subjects

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4